A novel specific signature of pediatric MOZ-CBP acute myeloid leukemia

Leukemia Research

Volumn 34, Issue 11, 2010, Pages

  Serravalle, Salvatore ^a   Melchionda, Fraia ^a   Astolfi, Annalisa ^a   Libri, Virginia ^a   Masetti, Riccardo ^a   Pession, Andrea ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HISTONE ACETYLTRANSFERASE PCAF; HYBRID PROTEIN; PROTEIN MOZ; PROTEIN MYB; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ANTINEOPLASTIC AGENT; MOZ-CBP FUSION PROTEIN, HUMAN; ONCOPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; BONE MARROW EXAMINATION; CANCER MORPHOLOGY; CASE REPORT; CELL ONCOGENE; CELL STRUCTURE; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME G BAND; CHROMOSOME TRANSLOCATION; COPY NUMBER VARIATION; DISEASE MARKER; FEMALE; GENE EXPRESSION PROFILING; GENE FUSION; GENE LOSS; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENETIC GAIN; GENOME ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; LETTER; LEUKEMIA REMISSION; LEUKEMOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; FATALITY; GENE TRANSLOCATION; GENETICS; TOXICITY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; FATAL OUTCOME; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; ONCOGENE PROTEINS, FUSION; TRANSLOCATION, GENETIC;

EID: 77957021653     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.05.026     Document Type: Letter

References (7)

1. Murati A., Adelaide J., Quilichini B., Remy V., Sainty D., Stoppa A.M., Bernard P., Olschwang S., Birnbaum D., Chaffanet M., et al. New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias. Haematologica 2007, 92(2):262-263.
2. Boyd E.M., Bench A.J., Vaghela K.J., Campbell G.N., Chowdhury F.B., Gudgin E.J., Scott M.A., Erber W.N. Therapy-related acute myeloid leukaemia with t(8;16)(p11;p13);MOZ-CBP and polymorphisms in detoxifying and DNA repair genes. Leukemia 2009, 23(6):1164-1167.
3. Terui K., Sato T., Sasaki S., Kudo K., Kamio T., Ito E. Two novel variants of MOZ-CBP fusion transcripts in spontaneously remitted infant leukemia with t(1;16;8)(p13;p13;p11), a new variant of t(8;16)(p11;p13). Haematologica 2008, 93(10):1591-1593.
4. Schmidt H.H., Strehl S., Thaler D., Strunk D., Sill H., Linkesch W., Jager U., Sperr W., Greinix H.T., Konig M., et al. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications. Leukemia 2004, 18(6):1115-1121.
5. Murati A., Gervais C., Carbuccia N., Finetti P., Cervera N., Adelaide J., Struski S., Lippert E., Mugneret F., Tigaud I., et al. Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases. Leukemia 2009, 23(1):85-94.
6. Pession A., Rizzari C., Putti M., Masetti R., Casale F., Fagioli F., Lo Nigro L., Luciani M., Micalizzi C., Menna G., et al. Results of the AIEOP AML 2002/01 Study for Treatment of Children with Acute Myeloid Leukemia. Blood 2009, 114(22):13.
7. Haferlach T., Kohlmann A., Klein H.U., Ruckert C., Dugas M., Williams P.M., Kern W., Schnittger S., Bacher U., Loffler H., et al. AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features. Leukemia 2009, 23(5):934-943.